Biography
Amanda Zoda is an associate in Weil’s Governance, Securities & Reporting Group and is based in New York. Amanda participates in advising U.S. public companies and foreign private issuers on securities law issues, disclosure, governance and compliance matters.
Amanda has been part of the teams advising:
- CBIZ, Inc. in its $5B sale to Grant Thornton Advisors LLC
- ChampionX Corporation in its sale to SLB
- Dun & Bradstreet in its $7.7 billion sale to Clearlake Capital Group
- Halozyme Therapeutics, Inc. in its $900 million acquisition of Elektrofi, Inc.
- Luminar Technologies, Inc. in its $110 million sale of Luminar Semiconductor, Inc. to Quantum Computing Inc.
- Luminar Technologies, Inc. in the sale of its LiDAR business to MicroVision Inc.
Amanda received her J.D., magna cum laude, from St John’s University School of Law, where she was Associate Managing Editor for the St. John’s Law Review and was a St. Thomas More Scholar. She received her B.A., summa cum laude, from the University of Albany.